Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Molecular Diagnostics: Page 5
Grail partners with LGBTQ+ group on study of cancer detection blood test
Grail has partnered with the Whitman-Walker Institute and the Cancer Support Community to assess the feasibility of using its multicancer early detection (MCED) Galleri blood test in a real-world setting.
September 1, 2023
Oxford Nanopore, IQVIA form nanopore sequencing partnership
Oxford Nanopore Technologies and IQVIA have struck a partnership to broaden access to nanopore sequencing technology, saying it will boost genomics research and patient care.
August 31, 2023
Cell-free DNA methylation blood test predicts risk of early-onset preeclampsia
Cell-free DNA methylation profiling may support the presymptomatic assessment of preeclampsia (PE) risk, according to a paper published on August 28 in Nature Medicine.
August 30, 2023
Gene expression test may improve diagnosis of febrile childhood diseases
A simple blood test based on patterns of gene expression could radically improve and speed up the diagnosis of febrile childhood diseases, say researchers.
August 30, 2023
CRISPR-Cas3 technique restores dystrophin function in iPSCs from DMD patients
Researchers have developed a dual CRISPR-Cas3 gene editing technique to restore dystrophin function in induced pluripotent stem cells (iPSCs) from patients with Duchenne muscular dystrophy (DMD).
August 24, 2023
CrisprBits, MolBio Diagnostics to collaborate on POC tests
The collaboration will leverage CrisprBits’ expertise in biotechnology and MolBio’s translation, manufacturing, and distribution abilities to build POC tests that detect pathogens and genetic markers.
August 23, 2023
Nonprofit health system adopts Immunexpress test for detecting sepsis
FirstHealth of the Carolinas, a nonprofit health system licensed for four hospitals in North Carolina, will use Immunexpress’ SeptiCyte Rapid test to help differentiate sepsis-positive cases from patients with infection-negative systemic inflammation.
August 23, 2023
Gene-specific approach recommended for variant pathogenicity prediction
A research team investigated the efficacy of gene-specific supervised machine learning in predicting the pathogenicity of rare BRCA1/2 missense variants compared to the disease-specific approach.
August 22, 2023
Viome Life Sciences raises $86.5M in Series C financing round
This round brings Viome's total financing to $175 million, the firm said. A previous Series C financing round in October raised $67 million.
August 21, 2023
Structural protein variants detected through nanopore technology
According to the team, the new protein characterization method could be readily integrated into existing portable nanopore sequencing devices to help rapidly build protein inventories of single cells and tissues.
August 21, 2023
GeninCode files pre-market notification with FDA for cardiovascular risk assessment test
The filing is part of GeninCode’s effort to expand its U.S. commercial distribution of CIC-SCORE; the company filed its pre-submission for GeninCode with the FDA last year.
August 18, 2023
Agilent closes $550M liquid biopsy unit after failing to find path to profits
When Agilent bought Resolution, it identified the company’s presence in fast-growing NGS technologies for precision oncology as a way to expand its addressable market; rather than realizing that opportunity, Agilent has ended up cutting its losses.
August 18, 2023
Previous Page
Page 5 of 190
Next Page